InfuSystem Holdings Free Cash Flow (FCF) History (INFU)
InfuSystem Holdings reported $23.8M in free cash flow for fiscal 2025, an increase of 23.14% from the previous fiscal year, with a free cash flow margin of 16.63%.
View full InfuSystem Holdings company overviewInfuSystem Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $23.8M | $4.5M | +23.14% | +16.63% |
| 2024 | 2024-12-31 | $19.4M | $9.2M | +89.89% | +14.36% |
| 2023 | 2023-12-31 | $10.2M | −$6.3M | −38.32% | +8.11% |
| 2022 | 2022-12-31 | $16.5M | −$801,000 | −4.62% | +15.04% |
| 2021 | 2021-12-31 | $17.3M | −$1.9M | −9.64% | +16.93% |
| 2020 | 2020-12-31 | $19.2M | $8.2M | +75.23% | +19.70% |
| 2019 | 2019-12-31 | $10.9M | −$161,000 | −1.45% | +13.50% |
| 2018 | 2018-12-31 | $11.1M | $3.5M | +45.92% | +105.27% |
| 2017 | 2017-12-31 | $7.6M | −$127,000 | −1.64% | +76.20% |
| 2016 | 2016-12-31 | $7.7M | $1.0M | +14.85% | +10.98% |
| 2015 | 2015-12-31 | $6.7M | $1.5M | +28.14% | +9.55% |
| 2014 | 2014-12-31 | $5.3M | $2.5M | +91.97% | +7.91% |
| 2013 | 2013-12-31 | $2.7M | $3.8M | — | +4.40% |
| 2012 | 2012-12-31 | −$1.1M | $375,000 | — | −1.85% |
| 2011 | 2011-12-31 | −$1.5M | −$9.8M | — | −2.68% |
| 2010 | 2010-12-31 | $8.4M | $3.3M | +64.21% | +17.72% |
| 2009 | 2009-12-31 | $5.1M | — | — | +13.08% |
InfuSystem Holdings quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.7M | −$106,000 | −1.56% | +18.10% |
| Q1 2026 | 2026-03-31 | $813,000 | −$836,000 | −50.70% | +2.41% |
| Q4 2025 | 2025-12-31 | $7.0M | −$408,000 | −5.51% | +19.30% |
| Q3 2025 | 2025-09-30 | $8.4M | −$1.4M | −14.13% | +23.06% |
| Q2 2025 | 2025-06-30 | $6.8M | $4.8M | +244.42% | +18.87% |
| Q1 2025 | 2025-03-31 | $1.6M | $1.5M | +745.64% | +4.75% |
| Q4 2024 | 2024-12-31 | $7.4M | $3.2M | +74.14% | +21.87% |
| Q3 2024 | 2024-09-30 | $9.8M | $5.7M | +136.58% | +27.74% |
| Q2 2024 | 2024-06-30 | $2.0M | −$303,000 | −13.32% | +5.85% |
| Q1 2024 | 2024-03-31 | $195,000 | $663,000 | — | +0.61% |
| Q4 2023 | 2023-12-31 | $4.3M | $95,000 | +2.29% | +13.38% |
| Q3 2023 | 2023-09-30 | $4.1M | $921,000 | +28.59% | +12.98% |
| Q2 2023 | 2023-06-30 | $2.3M | −$3.0M | −56.74% | +7.17% |
| Q1 2023 | 2023-03-31 | −$468,000 | −$4.4M | — | −1.54% |
| Q4 2022 | 2022-12-31 | $4.2M | $817,000 | +24.48% | +14.41% |
| Q3 2022 | 2022-09-30 | $3.2M | −$2.3M | −41.63% | +11.81% |
| Q2 2022 | 2022-06-30 | $5.3M | −$708,000 | −11.87% | +19.45% |
| Q1 2022 | 2022-03-31 | $3.9M | $1.4M | +55.19% | +14.57% |
| Q4 2021 | 2021-12-31 | $3.3M | −$4.0M | −54.79% | +12.59% |
| Q3 2021 | 2021-09-30 | $5.5M | −$2.7M | −32.88% | +20.77% |
| Q2 2021 | 2021-06-30 | $6.0M | $2.4M | +67.90% | +24.03% |
| Q1 2021 | 2021-03-31 | $2.5M | $2.5M | +8875.00% | +10.27% |
| Q4 2020 | 2020-12-31 | $7.4M | $9.1M | — | +29.88% |
| Q3 2020 | 2020-09-30 | $8.2M | $4.1M | +100.61% | +32.72% |
| Q2 2020 | 2020-06-30 | $3.6M | $4.9M | — | +13.67% |
| Q1 2020 | 2020-03-31 | $28,000 | $2.3M | — | +0.13% |
| Q4 2019 | 2019-12-31 | −$1.7M | −$684,000 | — | −8.03% |
| Q3 2019 | 2019-09-30 | $4.1M | $2.5M | +158.39% | +19.07% |
| Q2 2019 | 2019-06-30 | −$1.3M | −$3.5M | — | −6.63% |
| Q1 2019 | 2019-03-31 | −$2.3M | −$2.2M | — | −12.46% |
| Q4 2018 | 2018-12-31 | −$1.1M | −$1.9M | — | −32.84% |
| Q3 2018 | 2018-09-30 | $1.6M | −$349,000 | −18.04% | +54.61% |
| Q2 2018 | 2018-06-30 | $2.2M | $375,000 | +20.89% | +91.83% |
| Q1 2018 | 2018-03-31 | −$67,000 | $2.4M | — | −3.25% |
| Q4 2017 | 2017-12-31 | $891,000 | $3.5M | — | +29.35% |
| Q3 2017 | 2017-09-30 | $1.9M | $259,000 | +15.45% | +85.39% |
| Q2 2017 | 2017-06-30 | $1.8M | $4.2M | — | +82.60% |
| Q1 2017 | 2017-03-31 | −$2.5M | $480,000 | — | −97.62% |
| Q4 2016 | 2016-12-31 | −$2.7M | $4.8M | — | −15.75% |
| Q3 2016 | 2016-09-30 | $1.7M | $162,000 | +10.70% | +9.73% |
| Q2 2016 | 2016-06-30 | −$2.4M | −$1.8M | — | −13.14% |
| Q1 2016 | 2016-03-31 | −$2.9M | $2.1M | — | −16.05% |
| Q4 2015 | 2015-12-31 | −$7.4M | −$5.3M | — | −39.52% |
| Q3 2015 | 2015-09-30 | $1.5M | $1.8M | — | +8.27% |
| Q2 2015 | 2015-06-30 | −$625,000 | $330,000 | — | −3.69% |
| Q1 2015 | 2015-03-31 | −$5.1M | −$3.3M | — | −30.58% |
| Q4 2014 | 2014-12-31 | −$2.1M | −$3.5M | — | −13.05% |
| Q3 2014 | 2014-09-30 | −$246,000 | −$1.9M | — | −1.48% |
| Q2 2014 | 2014-06-30 | −$955,000 | −$769,000 | — | −5.83% |
| Q1 2014 | 2014-03-31 | −$1.8M | −$1.6M | — | −10.23% |
| Q4 2013 | 2013-12-31 | $1.4M | $4.0M | — | +7.98% |
| Q3 2013 | 2013-09-30 | $1.7M | −$512,000 | −23.15% | +10.80% |
| Q2 2013 | 2013-06-30 | −$186,000 | −$1.6M | — | −1.27% |
| Q1 2013 | 2013-03-31 | −$145,000 | $2.0M | — | −0.99% |
| Q4 2012 | 2012-12-31 | −$2.6M | −$745,000 | — | −16.09% |
| Q3 2012 | 2012-09-30 | $2.2M | $2.4M | — | +15.60% |
| Q2 2012 | 2012-06-30 | $1.4M | $670,000 | +89.21% | +10.10% |
| Q1 2012 | 2012-03-31 | −$2.1M | −$1.8M | — | −14.71% |
| Q4 2011 | 2011-12-31 | −$1.9M | −$5.2M | — | −13.30% |
| Q3 2011 | 2011-09-30 | −$143,000 | — | — | −0.99% |
| Q2 2011 | 2011-06-30 | $751,000 | — | — | +5.72% |
| Q1 2011 | 2011-03-31 | −$316,000 | — | — | −2.44% |
| Q3 2010 | 2010-09-30 | $3.4M | — | — | +26.33% |
InfuSystem Holdings free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $19.2M to $23.8M, a compound annual growth rate of 4.45%. InfuSystem Holdings's latest reported quarter, Q2 2026, generated $6.7M in free cash flow, a decrease of 1.56% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review InfuSystem Holdings filings at SEC.gov ↗